Recent Blog Articles
Tick season is expanding: Protect yourself against Lyme disease
What? Another medical form to fill out?
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Co-regulation: Helping children and teens navigate big emotions
Prostate Health Archive
Articles
PSA screening for prostate cancer
Two studies come to different conclusions about the benefits, leaving patients and their doctors to decide what makes sense.
PSA — Old controversies, new results
Many experts believe prostate cancer is the exception to the rule when it comes to screening. In fact, PSA screening may actually do more harm than good. Two studies, one conducted in the U.S. and the other in Europe, were hopefully going to settle the debate over the value of the PSA. While they gave us some answers, we are still a long way from settling the debate.
Moving beyond PSA
Genetic biomarkers may help doctors decide whether to perform a biopsy, determine the best treatment, and develop new targeted therapies for prostate cancer.
Using PSA to determine prognosis
Renowned radiation oncologist and researcher Anthony D’Amico, M.D., Ph.D. discusses his PSA research and its implications for prostate cancer treatment.
One couple’s story: Handling prostate cancer in the face of differing biopsies
Elliot and Elizabeth Boyd share their experience with a prostate cancer diagnosis, explain their next steps in light of seemingly contradictory test results, and offer advice to those coping with their diagnosis and weighing treatment options.
Raising prostate cancer awareness among African Americans: Two patients’ stories
Two prostate cancer survivors talk about the importance of prostate cancer education among African Americans and other men at high risk.
Androgen-independent prostate cancer: A patient’s story
Ken Gannon talks about his 13 year battle with prostate cancer and his experiences with second-line hormone therapies, investigational drugs, and four clinical trials, one of which nearly killed him.
A patient’s story: Why one man opted for lifestyle changes instead of treatment
Patient Ben Hunter explains why he decided to postpone treatment for prostate cancer and the lifestyle changes he made immediately following his diagnosis.
Choosing — and sticking with — active surveillance: A patient’s story
Patient Jeffrey Caruso explains why he decided to pursue active surveillance and under what circumstances he would opt to treat his prostate cancer.
Technology and decision-making: A patient’s story
How endorectal MRI helped one couple choose the “best” treatment for prostate cancer.
Recent Blog Articles
Tick season is expanding: Protect yourself against Lyme disease
What? Another medical form to fill out?
How do trees and green spaces enhance our health?
A muscle-building obsession in boys: What to know and do
Harvard Health Ad Watch: New drug, old song, clever tagline
Concussion in children: What to know and do
What color is your tongue? What's healthy, what's not?
Your amazing parathyroid glands
When — and how — should you be screened for colon cancer?
Co-regulation: Helping children and teens navigate big emotions
Free Healthbeat Signup
Get the latest in health news delivered to your inbox!
Sign Up